Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial

Schaefer, Ernst J.

doi:10.1001/jama.1994.03510370051031

Cited by 487Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial

Schaefer, Ernst J.·1994·JAMA

DOI 10.1001/jama.1994.03510370051031

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine the relationship between elevated levels of lipoprotein(a) [Lp(a)] and coronary heart disease (CHD) risk in a prospective study. DESIGN: Nested case-control study. The cohort consisted of participants in the Lipid Research Clinics Coronary Primary Prevention Trial. SETTING: Lipid research clinics. PARTICIPANTS: The Lipid Research Clinics Coronary Primary Prevention Trial participants (n = 3806) were men, aged 35 to 59 years, with plasma cholesterol levels of 6.85 mmol/L (265 mg/dL) or greater, low-density lipoprotein cholesterol levels of 4.91 mmol/L (190 mg/dL) or greater, and triglyceride levels less than 3.39 mmol/L. Subjects were randomly assigned to either cholestyramine or placebo treatment. The Lp(a) levels were measured in plasma samples obtained prior to randomization in 233 cases (participants who developed CHD in the course of the study) and 390 matched CHD-free controls. A total of 96.95% of the subjects were white, 2.25% were black, and 0.80% were of other race. MAIN OUTCOME MEASURE: Coronary heart disease (either fatal or nonfatal) events during a follow-up of 7 to 10 years. RESULTS: The Lp(a) levels were significantly higher (21%) in cases than in controls (23.7 mg/dL [0.59 mmol/L] and 19.5 mg/dL [0.49 mmol/L], respectively; P < .02). This difference was still statistically significant (P < .01) after controlling for age, body mass index, cigarette smoking, blood pressure, low-density lipoprotein cholesterol level, and high-density lipoprotein cholesterol level. When subjects were divided by treatment, both cholestyramine-treated and placebo-treated CHD subjects had Lp(a) levels 20% to 22% greater than their matched controls. However, possibly because of smaller sample sizes, these differences were no longer statistically significant. CONCLUSIONS: Our data are consistent with the concept that an elevated Lp(a) level is an independent risk factor for CHD in hypercholesterolemic white men.

Integrity signals

Registry

Crossref · 10.1001/jama.1994.03510370051031

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hyper-Lp(a)-lipoproteinemia is a risk factor for ASCVD.
“[Statement]Hyper-Lp(a)-lipoproteinemia is a risk factor for ASCVD. (Evidence level: E-1a)”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [223]

Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332 · see citing works
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895 · see citing works
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886 · see citing works
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,377 · see citing works
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257 · see citing works
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.
Boerwinkle, E., Leffert, C. C., Lin, J., Lackner, C., Chiesa, G., & Hobbs, H. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115855 · Cited by 958 · see citing works
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
Dahlén, G., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 910 · see citing works
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 699 · see citing works
Familial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 598 · see citing works
Self-citation
Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
Seed, M., Hoppichler, F., Reaveley, D. A., McCarthy, S., Thompson, G. R., Boerwinkle, E., & Utermann, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222104 · Cited by 584 · see citing works
A potential basis for the thrombotic risks associated with lipoprotein(a)
Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 581 · see citing works
Lipoprotein (a). Heterogeneity and biological relevance.
Scanu, A. M., & Fless, G. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114625 · Cited by 579 · see citing works
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
Rosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.301.6763.1248 · Cited by 538 · see citing works
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA · doi:10.1001/jama.1993.03510180065035 · Cited by 512 · see citing works
Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M. S., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.240 · Cited by 461 · see citing works
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Sandkamp, M., Funke, H., Schulte, H., Köhler, E., & Assmann, G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.20 · Cited by 417 · see citing works
Biased Selection of Controls for Case-Control Analyses of Cohort Studies
Lubin, J. H., & Gail, M. H. (1984) · Biometrics · doi:10.2307/2530744 · Cited by 414 · see citing works
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups
Sandholzer, C., Hallman, D. M., Saha, N., Sigurðsson, G., Lackner, C., Cs�sz�r, A., Boerwinkle, E., & Utermann, G. (1991) · Human Genetics · doi:10.1007/bf00201550 · Cited by 384 · see citing works
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants
Jauhiainen, M., Koskinen, P., Ehnholm, C., Frick, M. H., Mänttäri, M., Manninen, V., & Huttunen, J. K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90007-p · Cited by 354 · see citing works
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.
Jenner, J. L., Ordovás, J. M., Lamon‐Fava, S., Schaefer, M. M., Wilson, P. W. F., Castelli, W. P., & Schaefer, E. J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1135 · Cited by 338 · see citing works
Self-citation
Radioimmunoassay of human plasma Lp(a) lipoprotein
Albers, J. J., Adolphson, J. L., & Hazzard, W. R. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41683-9 · Cited by 269 · see citing works
Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].
Gaubatz, J. W., Ghanem, K., Guevara, J., Nava, M. L., Patsch, W., & Morrisett, J. D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42828-7 · Cited by 253 · see citing works
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
Wiklund, O., Olofsson, S.-O., Fager, G., Bondjers, G., Angelin, B., Erikson, M., & Berglund, L. (1990) · The Lancet · doi:10.1016/0140-6736(90)91242-3 · Cited by 197 · see citing works
Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice.
Hofmann, S. L., Eaton, D., Brown, M. S., McConathy, W. J., Goldstein, J. L., & Hammer, R. E. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114602 · Cited by 194 · see citing works
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
Rader, D. J., Cain, W. J., Zech, L. A., Usher, D. C., & Brewer, H. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116221 · Cited by 194 · see citing works
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.
Gavish, D., Azrolan, N., & Breslow, J. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114395 · Cited by 157 · see citing works
A New Serum Type System in Man — The Ld System
Berg, K. (1965) · Vox Sanguinis · doi:10.1111/j.1423-0410.1965.tb01404.x · Cited by 150 · see citing works
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease
Genest, J. J., Jenner, J. L., McNamara, J. R., Ordovás, J. M., Silberman, S. R., Wilson, P. W. F., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90862-f · Cited by 148 · see citing works
Self-citation
The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a)
Lamon‐Fava, S., Jiménez, D., Christian, J. C., Fabsitz, R. R., Reed, T., Carmelli, D., Castelli, W. P., Ordovás, J. M., Wilson, P. W. F., & Schaefer, E. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90191-5 · Cited by 127 · see citing works
Self-citation
Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.
Mbewu, A. D., Bhatnagar, D., Durrington, P. N., Hunt, L. P., Ishola, M., Arrol, S., Mackness, M., Lockley, P., & Miller, J. P. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.940 · Cited by 100 · see citing works
Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein
Simon, D. I., Fless, G. M., Scanu, A. M., & Loscalzo, J. (1991) · Biochemistry · doi:10.1021/bi00241a006 · Cited by 93 · see citing works
Oxidative modification of lipoprotein(a) and the effect of β-carotene
Naruszewicz, M., Selinger, E., & Davignon, J. (1992) · Metabolism · doi:10.1016/0026-0495(92)90012-y · Cited by 92 · see citing works
Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)
Seman, L., & Breckenridge, W. C. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-133 · Cited by 90 · see citing works
Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein
Rader, D. J. (1992) · JAMA · doi:10.1001/jama.267.8.1109 · Cited by 81 · see citing works
Chapter 4 Lipoprotein(a): structure, metabolism and epidemiology
Morrisett, J. D., Guyton, J. R., Gaubatz, J. W., & Gotto, A. M. (1987) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60198-2 · Cited by 56 · see citing works
Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels
Brewer, H. B. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-620990-7.50018-8 · Cited by 53 · see citing works
Effect of Sample Storage on the Assay of Lipoprotein(a) by Commercially Available Radial Immunodiffusion and Enzyme-Linked Immunosorbent Assay Kits
Craig, W. Y., Poulin, S., Forster, N. R., Neveux, L. M., Wald, N. J., & Ledue, T. B. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.4.550 · Cited by 50 · see citing works
Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man.
Meddings, J. B., & Dietschy, J. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.805 · Cited by 47 · see citing works
Twin research in coronary heart disease.
Berg, K. (1981) · PubMed · Cited by 29 · see citing works
Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia
Hiraga, T., Okubo, M., Kobayashi, T., Nakanishi, K., Sugimoto, T., & Murase, T. (1993) · Metabolism · doi:10.1016/0026-0495(93)90133-9 · Cited by 15 · see citing works
The effects of long term storage on serum Lp(a) levels
Craig, W. Y., & Ledue, T. B. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90264-h · Cited by 13 · see citing works

Flagged first, then by citations

Sorted by citations

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753 · see citing works
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · see citing works
Lipoprotein(a) and Coronary Heart Disease
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · see citing works
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works
Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study.
Mahoney, L., Burns, T., Stanford, W., Thompson, B., Witt, J., Rost, C. A., & Lauer, R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00461-0 · Cited by 693 · see citing works
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works
Primary Prevention of Coronary Heart Disease: Guidance From Framingham: A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609 · see citing works
Cardiovascular disease and chronic renal disease: A new paradigm
Sarnak, M. J., & Levey, A. S. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70239-3 · Cited by 581 · see citing works
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
Jellinger, P. S., Smith, D. A., Mehta, A., Ganda, O. P., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 527 · see citing works
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
Trégouët, D., König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel‐Nitschke, P., Perret, C., DeSuremain, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 474 · see citing works
Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
Assmann, G., Schulte, H., & von Eckardstein, A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00159-2 · Cited by 445 · see citing works
Lipoproteins, nutrition, and heart disease.
Schaefer, E. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 448 · see citing works
Self-citation
Thiazolidinediones: a new class of antidiabetic drugs
Day, C. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00023.x · Cited by 435 · see citing works
The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease
Muntner, P., Hamm, L. L., Kusek, J. W., Chen, J., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00006 · Cited by 406 · see citing works
Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger
Bostom, A. G. (1996) · JAMA · doi:10.1001/jama.1996.03540070040028 · Cited by 397 · see citing works
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand, M., Buckley, D., Freeman, M., Fu, R. F., Rogers, K. R., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 380 · see citing works
Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause
Shlipak, M. G. (2000) · JAMA · doi:10.1001/jama.283.14.1845 · Cited by 370 · see citing works
Simvastatin Lowers C-Reactive Protein Within 14 Days
Plenge, J. K., Hernandez, T. L., Weil, K. M., Poirier, P., Grunwald, G. K., Marcovina, S. M., & Eckel, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000029743.68247.31 · Cited by 351 · see citing works
Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood
Nowak‐Göttl, U., Sträter, R., Heinecke, A., Junker, R., Koch, H.-G., Schuierer, G. R., & von Eckardstein, A. (1999) · Blood · doi:10.1182/blood.v94.11.3678 · Cited by 343 · see citing works
Lipids, risk factors and ischaemic heart disease
Castelli, W. P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05851-0 · Cited by 337 · see citing works
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 335 · see citing works
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323 · see citing works
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients
Szalai, C., Duba, J., Prohászka, Z., Kalina, Á., Szabó, T., Nagy, B., Horváth, L., & Császár, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00423-3 · Cited by 317 · see citing works
Substituting Walnuts for Monounsaturated Fat Improves the Serum Lipid Profile of Hypercholesterolemic Men and Women
Zambón, D., Sabaté, J., Muñoz, S., Campero, B., Casals, E., Merlos, M., Laguna, J. C., & Ros, E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00005 · Cited by 309 · see citing works
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works
Risk factors for coronary heart disease: implications of gender
van Lennep, J. R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00388-1 · Cited by 295 · see citing works
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher, V. M. G. (1995) · JAMA · doi:10.1001/jama.1995.03530220037029 · Cited by 297 · see citing works
Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects
Ginsberg, H. N., Kris‐Etherton, P. M., Dennis, B., Elmer, P. J., Ershow, A. G., LeFevre, M. L., Pearson, T. A., Roheim, P. S., Ramakrishnan, R., Reed, R. G., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.441 · Cited by 294 · see citing works
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Ariyo, A. A., Thach, C. T., & Tracy, R. P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa001066 · Cited by 289 · see citing works
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
Boffa, M. B., & Koschinsky, M. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0153-2 · Cited by 289 · see citing works
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease<subtitle>Large-Scale Prospective Data</subtitle>
Bennet, A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.598 · Cited by 281 · see citing works
Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study
McNamara, J. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278 · see citing works
Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257 · see citing works
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.
Bostom, A. G., GAGNON, D. R., Cupples, L. A., Wilson, P. W. F., Jenner, J. L., Ordovás, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 254 · see citing works
Self-citation
Prevalence and Prognostic Value of Subclinical Left Ventricular Systolic Dysfunction by Global Longitudinal Strain in a Community-Based Cohort
Russo, C. A., Jin, Z., Elkind, M. S. V., Rundek, T., Homma, S., Sacco, R. L., & Tullio, M. R. D. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.154 · Cited by 252 · see citing works
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Thompson, G., Maher, V., Kitano, Y., Neuwirth, C., Davies, G., Matthews, S., Shortt, M., Rees, A., Mir, A., Henderson, A., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92961-4 · Cited by 257 · see citing works
Lipoprotein(a)
Berglund, L., & Ramakrishnan, R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000144010.55563.63 · Cited by 240 · see citing works
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans
Marcovina, S. M., Albers, J. J., Wijsman, E. M., ZHANG, Z., Chapman, N. H., & Kennedy, H. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37461-7 · Cited by 236 · see citing works
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
Kraft, H. G., Lingenhel, A., Köchl, S., Hoppichler, F., Kronenberg, F., Abe, A., Mühlberger, V., Schönitzer, D., & Utermann, G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.713 · Cited by 232 · see citing works
Lipoprotein(a) in renal disease
Kronenberg, F., Utermann, G., & Dieplinger, H. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90026-8 · Cited by 229 · see citing works
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study
Luc, G., Bard, J., Arveiler, D., Ferrières, J., Evans, A., Amouyel, P., Fruchart, J., & Ducimetière, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00026-6 · Cited by 227 · see citing works
Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
Nowak‐Göttl, U., Junker, R., Hartmeier, M., Koch, H.-G., Münchow, N., Assmann, G., & von Eckardstein, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.743 · Cited by 222 · see citing works
Lipoprotein(a), Measured With an Assay Independent of Apolipoprotein(a) Isoform Size, and Risk of Future Cardiovascular Events Among Initially Healthy Women
Danik, J. S., Rifai, N., Buring, J. E., & Ridker, P. M. (2006) · JAMA · doi:10.1001/jama.296.11.1363 · Cited by 215 · see citing works
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. A., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210 · see citing works
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta, V., & Cannon, R. O. (1996) · Circulation · doi:10.1161/01.cir.93.10.1928 · Cited by 202 · see citing works
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
Wild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194 · see citing works
Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Ikezaki, H., Lim, E., Cupples, L. A., Liu, C., Asztalos, B. F., & Schaefer, E. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019140 · Cited by 192 · see citing works
Self-citation
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk
von Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01126-8 · Cited by 186 · see citing works
The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.
Argraves, K. M., Kozarsky, K., Fallon, J. T., Harpel, P. C., & Strickland, D. K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119753 · Cited by 179 · see citing works
Lipoprotein(a)
Hobbs, H. H., & White, A. L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00005 · Cited by 178 · see citing works
Lipoprotein(a) as a risk factor for coronary artery disease
Marcovina, S. M., & Koschinsky, M. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00954-0 · Cited by 178 · see citing works
Lipoprotein Lp(a) Excess and Coronary Heart Disease
Stein, J. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320040005 · Cited by 178 · see citing works
Black Tea Consumption Reduces Total and LDL Cholesterol in Mildly Hypercholesterolemic Adults
Davies, M. J., Judd, J. T., Baer, D. J., Clevidence, B. A., Paul, D. R., Edwards, A. J., Wiseman, S. A., Muesing, R. A., & Chen, S. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.10.3298s · Cited by 177 · see citing works
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men
Paultre, F., Pearson, T. A., Weil, H., Tuck, C. H., Myerson, M. L., Rubin, J., Francis, C. K., Marx, H. F., Philbin, E. F., Reed, R. G., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2619 · Cited by 174 · see citing works
Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women
Orth‐Gomér, K., Mittleman, M. A., Schenck-Gustafsson, K. G., Wamala, S. P., Eriksson, M., Belkic, K. L., Kirkeeide, R. L., Svane, B., & ́n, L. R. (1997) · Circulation · doi:10.1161/01.cir.95.2.329 · Cited by 173 · see citing works
Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study)
Gotoh, T., Kuroda, T., Yamasawa, M., Nishinaga, M., Mitsuhashi, T., Seino, Y., Nagoh, N., Kayaba, K., Yamada, S., Matsuo, H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80263-x · Cited by 167 · see citing works
Dietary Fructose and Glucose Differentially Affect Lipid and Glucose Homeostasis
Schaefer, E. J., Gleason, J. A., & Dansinger, M. L. (2009) · Journal of Nutrition · doi:10.3945/jn.108.098186 · Cited by 165 · see citing works
Self-citation
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 160 · see citing works
Is Lipoprotein(a) an Independent Risk Factor for Ischemic Heart Disease in Men? The Quebec Cardiovascular Study
Cantin, B., Gagnon, F., Moorjani, S., Després, J., Lamarche, B., Lupien, P. J., & Dagenais, G. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00528-7 · Cited by 155 · see citing works
The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients
Kronenberg, F., Neyer, U., Lhotta, K., Trenkwalder, E., Auinger, M., Pribasnig, A., Meisl, T., König, P., & Dieplinger, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1051027 · Cited by 155 · see citing works
Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation
Ferrières, J., Lambert, J., Lussier‐Cacan, S., & Davignon, J. (1995) · Circulation · doi:10.1161/01.cir.92.3.290 · Cited by 154 · see citing works
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors
Tsimikas, S., Clopton, P., Brilakis, E. S., Marcovina, S. M., Khera, A., Miller, E. R., de Lemos, J. A., & Witztum, J. L. (2009) · Circulation · doi:10.1161/circulationaha.108.836940 · Cited by 151 · see citing works
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Harjai, K. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00009 · Cited by 150 · see citing works
Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
Ridker, P. M. (1995) · JAMA · doi:10.1001/jama.1995.03520400039041 · Cited by 141 · see citing works
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
SEMAN, L. J., DeLuca, C., Jenner, J. L., Cupples, L. A., McNamara, J. R., Wilson, P. W. F., Castelli, W. P., Ordovás, J. M., & Schaefer, E. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1039 · Cited by 138 · see citing works
Self-citation
Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
Berg, K., Dahlén, G. H., Christophersen, B. O., Cook, T. J., KJEKSHUS, J. K., & Pedersen, T. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb04342.x · Cited by 136 · see citing works
Micronised Fenofibrate
Adkins, J. C., & Faulds, D. M. (1997) · Drugs · doi:10.2165/00003495-199754040-00007 · Cited by 136 · see citing works
Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and Women
Nguyen, T. T., Ellefson, R. D., Hodge, D. O., Bailey, K. R., Kottke, T. E., & Abu-Lebdeh, H. S. (1997) · Circulation · doi:10.1161/01.cir.96.5.1390 · Cited by 133 · see citing works
Apolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial Cells
Poon, M., Zhang, X., Dunsky, K. G., Taubman, M. B., & Harpel, P. C. (1997) · Circulation · doi:10.1161/01.cir.96.8.2514 · Cited by 131 · see citing works
An update on coronary risk factors
Kannel, W. B., & Wilson, P. W. F. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30016-5 · Cited by 130 · see citing works
Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians’ Health Study
Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., & Marcovina, S. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030031 · Cited by 127 · see citing works
No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
Moliterno, D. J., Jokinen, E. V., Miserez, A. R., Lange, R. A., Willard, J. E., Boerwinkle, E., Hillis, L. D., & Hobbs, H. H. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.850 · Cited by 126 · see citing works
Trans fatty acids: Implications for health, analytical methods, incidence in edible fats and intake
Precht, D., & Molkentin, J. (1995) · Food / Nahrung · doi:10.1002/food.19950390503 · Cited by 121 · see citing works
Beyond LDL Cholesterol Reduction
Superko, H. R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2351 · Cited by 119 · see citing works
Lp(a): When and how to measure it
Cegla, J., France, M. W., Marcovina, S. M., & Neely, R. D. G. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220968473 · Cited by 117 · see citing works
Micronised Fenofibrate
Keating, G. M., & Ormrod, D. J. (2002) · Drugs · doi:10.2165/00003495-200262130-00013 · Cited by 113 · see citing works
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study
Bostom, A. G., Shemin, D. G., Lapane, K. L., Sutherland, P. A., Nadeau, M., Wilson, P. W. F., Yoburn, D. C., Bausserman, L., Tofler, G. H., Jacques, P. F., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05865-0 · Cited by 112 · see citing works
Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness
Schreiner, P. J., HEISS, G. M., Tyroler, H. A., Morrisett, J. D., DAVIS, C. E., & Smith, R. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.471 · Cited by 108 · see citing works
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men
Cremer, P., Nagel, D., Mann, H., Labrot, B., Müller-Berninger, R., Elster, H., & Seidel, D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06030-3 · Cited by 108 · see citing works
Androgen and progestagen effects on plasma lipids
Bagatell, C. J., & Bremner, W. J. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80016-6 · Cited by 107 · see citing works
Improving Global Vascular Risk Prediction With Behavioral and Anthropometric Factors
Sacco, R. L., Khatri, M., Rundek, T., Xu, Q., Gardener, H. E., Boden-Albala, B. M., Tullio, M. R. D., Homma, S., Elkind, M. S. V., & Paik, M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.047 · Cited by 105 · see citing works
Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets
Judd, J. T., Baer, D. J., Clevidence, B. A., Muesing, R. A., Clevidence, B. A., Chen, S. C., Weststrate, J. A., Clevidence, B. A., Meijer, G. W., Janet, W., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.768 · Cited by 105 · see citing works
Self-citation
Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Wilson, P. W. F., Ordovás, J. M., & Schaefer, E. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1224 · Cited by 105 · see citing works
Self-citation
C/T Polymorphism in the 5′ Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
Zysow, B. R., Lindahl, G. E., Wade, D. P., Knight, B. L., & Lawn, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.58 · Cited by 104 · see citing works
Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina
Bogaty, P. M., Poirier, P., Simard, S., Boyer, L., Solymoss, S., & Dagenais, G. R. (2001) · Circulation · doi:10.1161/01.cir.103.25.3062 · Cited by 103 · see citing works
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Foody, J. M., MILBERG, J. A., Robinson, K., Pearce, G. L., Jacobsen, D. W., & Sprecher, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.493 · Cited by 103 · see citing works
Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time
Kronenberg, F., Trenkwalder, E., Dieplinger, H., & Utermann, G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1568 · Cited by 101 · see citing works
Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a)
Ernst, A., Helmhold, M., Brunner, C., Pethö‐Schramm, A., Armstrong, V. W., & Müller, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6227 · Cited by 101 · see citing works
Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
Deb, A., & Caplice, N. M. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270503 · Cited by 99 · see citing works
Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India
Misra, A., Sharma, R., Pandey, R., & Khanna, N. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601214 · Cited by 99 · see citing works
Task force 3. Spectrum of risk factors for coronary heart disease
Pasternak, R. C., Grundy, S. M., Levy, D. A., & Thompson, P. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87731-x · Cited by 99 · see citing works
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Hopkins, P. N., Wu, L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2783 · Cited by 99 · see citing works
Lipoproteins, nutrition, aging, and atherosclerosis
Schaefer, E. J., Lichtenstein, A. H., Lamon‐Fava, S., McNamara, J., & Ordovás, J. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.726s · Cited by 97 · see citing works
Self-citation
Plasma Lipoprotein (a) Levels in Men and Women Consuming Diets Enriched in Saturated, Cis -, or Trans -Monounsaturated Fatty Acids
Clevidence, B. A., Judd, J. T., Schaefer, E. J., Jenner, J. L., Lichtenstein, A. H., Muesing, R. A., Wittes, J. T., & Sunkin, M. E. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1657 · Cited by 95 · see citing works
Self-citation
Conditional Risk Factors for Atherosclerosis
Kullo, I. J., & Ballantyne, C. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.2.219 · Cited by 93 · see citing works
Lipoprotein(a) in Health and Disease
Kronenberg, F., Steinmetz, A., Kostner, G. M., & Dieplinger, H. (1996) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369609080056 · Cited by 90 · see citing works
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Lamon‐Fava, S., Marcovina, S. M., Albers, J. J., Kennedy, H., DeLuca, C., White, C. C., Cupples, L. A., McNamara, J. R., SEMAN, L. J., Bongard, V., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012526 · Cited by 89 · see citing works
Self-citation
Lipoprotein(a) in Cardiovascular Diseases
Malaguarnera, M., Vacante, M., Russo, C., Malaguarnera, G., Antic, T., Malaguarnera, L., Bella, R., Pennisi, G., Galvano, F., & Frigiola, A. (2012) · BioMed Research International · doi:10.1155/2013/650989 · Cited by 88 · see citing works
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
Nicholls, S. J., Tang, W. H. W., Scoffone, H. M., Brennan, D. M., Hartiala, J., Allayee, H., & Hazen, S. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008961 · Cited by 88 · see citing works
Thromboembolism in Newborns, Infants and Children
Kosch, A., Schlegel, N., & Nowak‐Göttl, U. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616244 · Cited by 88 · see citing works

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.271.13.999 · Cited by 96 · see citing works
Self-citation
P5528Extremely elevated lipoprotein (a) as an independent risk factor for coronary heart disease in large patient cohort
Poudel, M. R., Kirana, S., Mellwig, K., Horstkotte, D., Knabbe, C., Hinse, D., Sauzet, O., Stoyanova, D., Gottfried, R., Scholtz, W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz746.0475
Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?
Gurewich, V. (1994) · JAMA · doi:10.1001/jama.271.13.1025 · Cited by 27 · see citing works
Lipoprotein(a) in coronary heart disease: a case-control study.
Gupta, R., Kastia, S., Rastogi, S. S., Kaul, V., Nagar, R., & Enas, E. A. (2000) · PubMed · Cited by 21 · see citing works
Lipoprotein(a) in Coronary Heart Disease
Gurewich, V. (1994) · JAMA · doi:10.1001/jama.1994.03510370077037

Authors: Schaefer, E. J.
Affiliations: Tufts University (US)
Corresponding author: Schaefer, Ernst J.
ORCID: Schaefer, Ernst J.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1994-04-06
Volume: 271
Issue: 13
Pages: 999
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1994.03510370051031
OpenAlex: W2085959182
Cited by: 487
References: 41
Citations by year: 2026: 2 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 4 · 2017: 10 · 2016: 9 · 2015: 10 · 2014: 3 · 2013: 5 · 2012: 10
FWCI: 57.73
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HV83-03)
Topics: Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords: lipoprotein(a), coronary artery disease, cardiovascular risk factors, hypercholesterolemia, cholestyramine, men, LDL cholesterol, primary prevention
MeSH terms: Adult, Aged, Cholestyramine Resin, Coronary Disease, Humans, Hypercholesterolemia, Lipids, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Risk Factors, Logistic Models, Case-Control Studies, Lipoprotein(a)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks